Halozyme Therapeutics, Inc.
NASDAQ:HALO
57.15 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 829.253 | 660.116 | 443.31 | 267.594 | 195.992 | 151.862 | 316.613 | 146.691 | 135.057 | 75.334 | 54.799 | 42.325 | 56.086 | 13.624 | 13.671 | 8.764 | 3.8 | 0.982 | 0.127 | 0 | 0.026 | 0.088 | 0.025 |
| Cost of Revenue
| 192.361 | 139.304 | 81.413 | 43.367 | 45.546 | 10.136 | 31.152 | 33.206 | 29.245 | 22.732 | 6.246 | 1.094 | 0.258 | 0.985 | 0.312 | 0.332 | 0.24 | 0.437 | 0.052 | 0 | 0.027 | 0.05 | 0.016 |
| Gross Profit
| 636.892 | 520.812 | 361.897 | 224.227 | 150.446 | 141.726 | 285.461 | 113.485 | 105.812 | 52.602 | 48.554 | 41.231 | 55.829 | 12.639 | 13.359 | 8.432 | 3.559 | 0.545 | 0.075 | 0 | -0.001 | 0.038 | 0.009 |
| Gross Profit Ratio
| 0.768 | 0.789 | 0.816 | 0.838 | 0.768 | 0.933 | 0.902 | 0.774 | 0.783 | 0.698 | 0.886 | 0.974 | 0.995 | 0.928 | 0.977 | 0.962 | 0.937 | 0.555 | 0.591 | 0 | -0.05 | 0.434 | 0.358 |
| Reseach & Development Expenses
| 76.363 | 66.607 | 35.672 | 34.236 | 140.804 | 150.252 | 150.643 | 150.842 | 93.236 | 79.696 | 96.64 | 70.044 | 57.563 | 51.774 | 56.614 | 44.233 | 20.554 | 9.215 | 10.22 | 6.517 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 60.804 | 53.816 | 45.853 | 40.028 | 35.942 | 32.348 | 24.812 | 18.104 | 15.123 | 15.203 | 14.634 | 11.155 | 6.913 | 3.417 | 2.571 | 0.078 | 0 | 0.047 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 |
| SG&A
| 149.182 | 143.526 | 50.323 | 45.736 | 77.252 | 60.804 | 53.816 | 45.853 | 40.028 | 35.942 | 32.348 | 24.812 | 18.104 | 15.123 | 15.203 | 14.634 | 11.155 | 6.913 | 3.417 | 2.571 | 0.078 | 0 | 0.049 |
| Other Expenses
| 73.773 | 43.148 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.014 | 257.834 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.077 | 0 |
| Operating Expenses
| 299.318 | 253.281 | 85.995 | 79.972 | 218.056 | 211.056 | 204.459 | 196.695 | 133.264 | 115.638 | 128.987 | 94.856 | 75.668 | 66.896 | 71.818 | 58.867 | 31.709 | 16.128 | 13.637 | 9.088 | 0.078 | 0.077 | 0.049 |
| Operating Income
| 337.574 | 267.531 | 275.902 | 144.255 | -67.61 | -69.33 | 81.002 | -83.21 | -27.452 | -63.036 | -80.434 | -53.625 | -19.839 | -54.258 | -58.458 | -50.435 | -28.15 | -15.583 | -13.561 | -9.088 | -0.079 | -0.039 | -0.04 |
| Operating Income Ratio
| 0.407 | 0.405 | 0.622 | 0.539 | -0.345 | -0.457 | 0.256 | -0.567 | -0.203 | -0.837 | -1.468 | -1.267 | -0.354 | -3.982 | -4.276 | -5.755 | -7.409 | -15.873 | -106.607 | 0 | -3.077 | -0.449 | -1.609 |
| Total Other Income Expenses Net
| 29.517 | -18.613 | -27.384 | -14.953 | -4.641 | 7.578 | 2.592 | 1.326 | 0.422 | 0.242 | 0.229 | 0.014 | 0.006 | 0.967 | 0.098 | 1.718 | 0 | 0 | 0.286 | -0.004 | 0 | -0.025 | 0 |
| Income Before Tax
| 348.329 | 248.918 | 248.518 | 129.302 | -72.251 | -79.793 | 61.61 | -101.861 | -32.231 | -68.375 | -83.479 | -53.552 | -19,769.851 | -53.242 | -58.361 | -48.717 | 0 | 0 | -13.275 | -9.091 | 0 | -0.064 | -0.04 |
| Income Before Tax Ratio
| 0.42 | 0.377 | 0.561 | 0.483 | -0.369 | -0.525 | 0.195 | -0.694 | -0.239 | -0.908 | -1.523 | -1.265 | -352.489 | -3.908 | -4.269 | -5.559 | 0 | 0 | -104.359 | 0 | 0 | -0.734 | -1.606 |
| Income Tax Expense
| 66.735 | 46.789 | -154.192 | 0.217 | -0.011 | 0.537 | -1.361 | 1.162 | 3.524 | 3.819 | 2.047 | -1.138 | -1.165 | -1.016 | 0 | -0.063 | -4.254 | -0.831 | -0.286 | 0.004 | 0.079 | 0.001 | 0 |
| Net Income
| 281.594 | 202.129 | 402.71 | 129.085 | -72.24 | -80.33 | 62.971 | -103.023 | -32.231 | -68.375 | -83.479 | -53.552 | -19.77 | -53.242 | -58.361 | -48.654 | -23.896 | -14.752 | -13.275 | -9.091 | -0.079 | -0.065 | -0.04 |
| Net Income Ratio
| 0.34 | 0.306 | 0.908 | 0.482 | -0.369 | -0.529 | 0.199 | -0.702 | -0.239 | -0.908 | -1.523 | -1.265 | -0.352 | -3.908 | -4.269 | -5.552 | -6.289 | -15.026 | -104.359 | 0 | -3.077 | -0.744 | -1.606 |
| EPS
| 2.13 | 1.48 | 2.86 | 0.95 | -0.5 | -0.56 | 0.46 | -0.81 | -0.25 | -0.56 | -0.74 | -0.48 | -0.19 | -0.56 | -0.67 | -0.61 | -0.32 | -0.24 | -0.26 | -0.26 | -0.012 | -0.014 | -0.033 |
| EPS Diluted
| 2.1 | 1.44 | 2.74 | 0.91 | -0.5 | -0.56 | 0.45 | -0.81 | -0.25 | -0.56 | -0.74 | -0.48 | -0.19 | -0.56 | -0.67 | -0.61 | -0.32 | -0.24 | -0.26 | -0.26 | -0.012 | -0.014 | -0.033 |
| EBITDA
| 422.43 | 310.679 | 275.902 | 144.255 | -67.61 | -69.33 | 81.002 | -83.21 | -27.452 | -63.036 | -80.434 | -53.625 | -19.845 | -53.717 | -57.015 | -49.387 | -27.574 | -15.339 | -13.641 | -8.961 | -0.079 | -0.014 | -0.04 |
| EBITDA Ratio
| 0.509 | 0.471 | 0.622 | 0.539 | -0.345 | -0.457 | 0.256 | -0.567 | -0.203 | -0.837 | -1.468 | -1.267 | -0.354 | -3.943 | -4.17 | -5.635 | -7.257 | -15.624 | -107.234 | 0 | -3.077 | -0.163 | -1.611 |